MASI vs. ITGR, LIVN, TMDX, CNMD, INSP, VKTX, ITCI, GMED, JAZZ, and EXEL
Should you be buying Masimo stock or one of its competitors? The main competitors of Masimo include Integer (ITGR), LivaNova (LIVN), TransMedics Group (TMDX), CONMED (CNMD), Inspire Medical Systems (INSP), Viking Therapeutics (VKTX), Intra-Cellular Therapies (ITCI), Globus Medical (GMED), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL). These companies are all part of the "medical" sector.
Masimo (NASDAQ:MASI) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability.
Integer has lower revenue, but higher earnings than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.
Masimo presently has a consensus target price of $137.43, suggesting a potential upside of 0.95%. Integer has a consensus target price of $120.50, suggesting a potential upside of 9.97%. Given Integer's stronger consensus rating and higher possible upside, analysts plainly believe Integer is more favorable than Masimo.
Integer has a net margin of 6.01% compared to Masimo's net margin of 3.98%. Masimo's return on equity of 13.77% beat Integer's return on equity.
Masimo received 78 more outperform votes than Integer when rated by MarketBeat users. Likewise, 64.02% of users gave Masimo an outperform vote while only 63.39% of users gave Integer an outperform vote.
86.0% of Masimo shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 9.7% of Masimo shares are owned by insiders. Comparatively, 2.0% of Integer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Integer had 18 more articles in the media than Masimo. MarketBeat recorded 28 mentions for Integer and 10 mentions for Masimo. Masimo's average media sentiment score of 0.64 beat Integer's score of 0.21 indicating that Masimo is being referred to more favorably in the media.
Masimo has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.
Summary
Masimo and Integer tied by winning 9 of the 18 factors compared between the two stocks.
Get Masimo News Delivered to You Automatically
Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools